rs9555703
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_001846.4(COL4A2):c.1432+100A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.252 in 765,636 control chromosomes in the GnomAD database, including 26,324 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.23 ( 4444 hom., cov: 33)
Exomes 𝑓: 0.26 ( 21880 hom. )
Consequence
COL4A2
NM_001846.4 intron
NM_001846.4 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.198
Publications
9 publications found
Genes affected
COL4A2 (HGNC:2203): (collagen type IV alpha 2 chain) This gene encodes one of the six subunits of type IV collagen, the major structural component of basement membranes. The C-terminal portion of the protein, known as canstatin, is an inhibitor of angiogenesis and tumor growth. Like the other members of the type IV collagen gene family, this gene is organized in a head-to-head conformation with another type IV collagen gene so that each gene pair shares a common promoter. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (REVEL=0.002).
BP6
Variant 13-110457535-A-G is Benign according to our data. Variant chr13-110457535-A-G is described in ClinVar as Benign. ClinVar VariationId is 1271299.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.295 is higher than 0.05.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| COL4A2 | ENST00000360467.7 | c.1432+100A>G | intron_variant | Intron 21 of 47 | 5 | NM_001846.4 | ENSP00000353654.5 |
Frequencies
GnomAD3 genomes AF: 0.228 AC: 34652AN: 152036Hom.: 4444 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
34652
AN:
152036
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.231 AC: 37023AN: 160604 AF XY: 0.238 show subpopulations
GnomAD2 exomes
AF:
AC:
37023
AN:
160604
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.257 AC: 157944AN: 613482Hom.: 21880 Cov.: 7 AF XY: 0.260 AC XY: 85470AN XY: 329008 show subpopulations
GnomAD4 exome
AF:
AC:
157944
AN:
613482
Hom.:
Cov.:
7
AF XY:
AC XY:
85470
AN XY:
329008
show subpopulations
African (AFR)
AF:
AC:
2324
AN:
16528
American (AMR)
AF:
AC:
5130
AN:
35368
Ashkenazi Jewish (ASJ)
AF:
AC:
4292
AN:
20072
East Asian (EAS)
AF:
AC:
2819
AN:
32120
South Asian (SAS)
AF:
AC:
16187
AN:
63660
European-Finnish (FIN)
AF:
AC:
11281
AN:
48256
Middle Eastern (MID)
AF:
AC:
709
AN:
4154
European-Non Finnish (NFE)
AF:
AC:
107631
AN:
361382
Other (OTH)
AF:
AC:
7571
AN:
31942
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.483
Heterozygous variant carriers
0
6575
13150
19726
26301
32876
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
1002
2004
3006
4008
5010
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.228 AC: 34653AN: 152154Hom.: 4444 Cov.: 33 AF XY: 0.224 AC XY: 16653AN XY: 74382 show subpopulations
GnomAD4 genome
AF:
AC:
34653
AN:
152154
Hom.:
Cov.:
33
AF XY:
AC XY:
16653
AN XY:
74382
show subpopulations
African (AFR)
AF:
AC:
6036
AN:
41544
American (AMR)
AF:
AC:
2625
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
AC:
812
AN:
3468
East Asian (EAS)
AF:
AC:
499
AN:
5158
South Asian (SAS)
AF:
AC:
1178
AN:
4830
European-Finnish (FIN)
AF:
AC:
2360
AN:
10590
Middle Eastern (MID)
AF:
AC:
43
AN:
294
European-Non Finnish (NFE)
AF:
AC:
20296
AN:
67948
Other (OTH)
AF:
AC:
441
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1369
2738
4106
5475
6844
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
366
732
1098
1464
1830
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
520
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
Jun 29, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.